NASDAQ: CYTHCyclo Therapeutics Inc Stock Ownership - Who owns Cyclo Therapeutics?
Insider buying vs selling
Have Cyclo Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| N. Scott Fine | Chief Executive Officer | 2023-10-20 | 299,402 | $0.71 | $212.58kBuy |
| Francis Patrick Ostronic | Director | 2023-10-20 | 59,881 | $0.71 | $42.52kBuy |
| Rafael Holdings Inc | 10% Owner | 2023-10-20 | 2,514,970 | $0.71 | $1.79MBuy |
| Markus Sieger | Director | 2023-10-20 | 59,881 | $0.71 | $42.52kBuy |
| Jeffrey Tate | Chief Operating Officer | 2023-10-20 | 29,941 | $0.71 | $21.26kBuy |
| Rafael Holdings Inc | 10% Owner | 2023-08-01 | 4,000,000 | $1.25 | $5.00MBuy |
CYTH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CYTH insiders and whales buy or sell their stock.
CYTH Shareholders
What type of owners hold Cyclo Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Armistice Capital LLC | 110.01% | 31,591,538 | $38.23M | Insider |
| Novit LP | 74.93% | 21,517,582 | $26.04M | Insider |
| Rafael Holdings Inc | 31.45% | 9,029,940 | $10.93M | Insider |
| George L. Fails | 5.87% | 1,685,221 | $2.04M | Insider |
| Joseph J. Farnan Jr. | 4.67% | 1,340,000 | $1.62M | Insider |
| N. Scott Fine | 2.59% | 743,804 | $900.00k | Insider |
| Founders Fund V Management LLC | 1.67% | 480,708 | $581.66k | Institution |
| Vanguard Group Inc | 1.24% | 355,223 | $429.82k | Institution |
| Francis Patrick Ostronic | 1.18% | 338,028 | $409.01k | Insider |
| Markus Sieger | 1.08% | 310,679 | $375.92k | Insider |
CYTH vs Pharmaceutical Stocks
Cyclo Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.